Stock Rich List
#6642 on the rich list of 14,644 insiders

Robert I. Blum

President & CEO at Cytokinetics. Based in South San Francisco, California.

$14.4M
in disclosed stock, +$39K (+0.27%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
6642nd of 14,644
Companies held
1
Largest holding
CYTK, 100.0% of total
Latest SEC filing
Nov 16, 2026

What the $14.4M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Cytokinetics CYTK
Common Stock
Directly278,544$51.46$14.3M99.3%Form 4, Nov 16, 2026
Cytokinetics CYTK
Common Stock
Through Trust 1. Beneficial Ownership disclaimed.2,083$51.46$107K0.7%Form 4, Nov 16, 2026

Share counts are the amounts Robert I. Blum reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Nov 16, 2026SoldCYTK5,077$53.22$270KView
Nov 16, 2026SoldCYTK2,223$54.08$120KView
Nov 16, 2026SoldCYTK200$55.21$11KView
Nov 2, 2026SoldCYTK7,500$62.81$471KView
Oct 12, 2026SoldCYTK7,500$62.88$472KView
Sep 28, 2026SoldCYTK7,500$65.46$491KView
Sep 15, 2026SoldCYTK97,926$69.33$6.8MView
Sep 14, 2026SoldCYTK7,500$73.44$551KView
Aug 31, 2026SoldCYTK7,500$70.24$527KView
Aug 10, 2026SoldCYTK7,500$76.76$576KView
Jul 27, 2026SoldCYTK7,500$80.87$607KView
Jul 13, 2026SoldCYTK10$82.02$820View
Jul 13, 2026SoldCYTK7,490$82.02$614KView
Jul 1, 2026SoldCYTK7,500$84.92$637KView
Jun 15, 2026SoldCYTK7,500$70.46$528KView
May 27, 2026SoldCYTK7,500$77.21$579KView
May 14, 2026SoldCYTK7,500$77.92$584KView
Apr 29, 2026SoldCYTK7,500$59.62$447KView
Apr 15, 2026SoldCYTK7,500$65.38$490KView
Apr 1, 2026SoldCYTK7,500$66.63$500KView
Mar 17, 2026SoldCYTK12,673$62.15$788KView
Mar 17, 2026SoldCYTK23,928$62.15$1.5MView
Mar 9, 2026SoldCYTK7,931$60.72$482KView
Oct 30, 2025SoldCYTK5,000$62.86$314KView
Oct 16, 2025SoldCYTK5,000$60.03$300KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
6639Mark G. Foletta
Director, DexCom. San Diego, CA
$14.5M−$509K (−3.40%)
6640Duston Williams
Chief Financial Officer, Nutanix. San Jose, CA
$14.5M−$30K (−0.21%)
6641Richard E. Perlman
Director, Onterris. North Little Rock, AR
$14.4M−$353K (−2.38%)
6642Robert I. Blum
President & CEO, Cytokinetics. South San Francisco, CA
$14.4M+$39K (+0.27%)
6643Louis C. McMurray
Director, Community West Bancshares. Fresno, CA
$14.4M−$258K (−1.76%)
6644Gerald A. Ducey Jr.
Pres. - Strategic Operations, Quanta Services. Houston, TX
$14.4M−$373K (−2.52%)
6645Joseph F. Mazzella
Director, PennyMac Financial Services. Westlake Village, CA
$14.4M−$383K (−2.59%)

Other Cytokinetics insiders

All CYTK insiders

Questions

How much stock does Robert I. Blum own?

Robert I. Blum holds $14,441,065 in listed stock based on SEC filings and current prices, mostly Cytokinetics (CYTK). That ranks 6642nd on the Stock Rich List.

Is this Robert I. Blum's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Robert I. Blum last buy or sell stock?

The most recent open-market trade on file is a sale of 5,077 CYTK shares on Nov 16, 2026 at $53.22.